Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus

INTRODUCTION: To investigate effects of Sitagliptin on the enhancement of beta-cell function, reducing insulin resistance, serum glucagon like peptide-1 (GLP-1) concentrations and blood glucose in patients with type 2 diabetes mellitus (T2D) and suggest one of the underlying mechanisms on beta-cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Tuan Dinh, Nguyen, Nga Thi Phi, Nguyen, Son Tien, Tran, Hoa Thi Thanh, Nguyen, Lan Thi Ho, Duong, Hoang Huy, Nguyen, Ha Manh, Do, Binh Nhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310979/
https://www.ncbi.nlm.nih.gov/pubmed/32606870
http://dx.doi.org/10.2147/DMSO.S255071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310979/
https://www.ncbi.nlm.nih.gov/pubmed/32606870
http://dx.doi.org/10.2147/DMSO.S255071

Ejemplares similares